Developmental Therapeutics

9 currently open clinical trials

A phase I trial with TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors
SAKK 65/16
NAPAGE: Nab-paclitaxel and gemcitabine for advanced soft tissue sarcomas
SAKK 57/16
Trial with the ATR Inhibitor BAY-1895344 in Patients with advanced solid Tumors and Lymphomas (first use in humans)
SAKK 69/17
Combination therapy with copanlisib and venetoclax in B-cell non-Hodgkin’s lymphoma
SAKK 66/18
Alpine Tumor Immunology Registry
SAKK 80/19 Alpine TIR
Treatment result and prognosis for cancer patients with a coronavirus infection
SAKK 80/20 CaSA
Thermal laser ablation and intratumoral injection of IP-001 in patients with advanced solid tumors
SAKK 66/17
Radio-chemotherapy improvement for locally advanced rectal cancer
SAKK 41/16
Stimulating the immune system to fight against squamous cell carcinoma
SAKK 11/16
All cancer types